J Bacteriol Virol.  2012 Sep;42(3):203-210. 10.4167/jbv.2012.42.3.203.

Mutations in gyrA and parC Genes and Plasmid-Mediated Quinolone Resistance in Non-typhoid Salmonella Isolated from Pediatric Patients with Diarrhea in Seoul

• Jin YH
• Jung JH
• Jeon SJ
• Lee JK
• Oh YH
• Choi SM
• Chae YZ

• KMID: 1434749
• DOI: http://doi.org/10.4167/jbv.2012.42.3.203

Abstract

A total of 91 non-typhoid Salmonella isolated from pediatric patients with diarrhea in Seoul from 2003 to 2009 was tested for antimicrobial susceptibility of nalidixic acid (NA). Forty strains of NA resistance or intermediate susceptible non-typhoid Salmonella were identified and their minimum inhibitory concentrations (MICs) of NA, ciprofloxacin (CIP), and norfloxacin (NOR) were determined. Of the 40 isolates, 26 were resistant to NA (MIC >256 microg/ml). Only one isolate was high-level resistant to CIP (12 microg/ml) and NOR (48 microg/ml). Mutations in gyrA and parC genes were studied by PCR and sequencing. All NA-resistant isolates carried point mutations in the gyrA quinolone resistance determining regions (QRDR) at codon 83 or 87 (MICs of NA, >256 microg/ml; MICs of CIP, 0.047~0.25 microg/ml; MICs of NOR, 0.38~1.5 microg/ml). A double change in GyrA was found in one Salmonella Enteritidis (MIC of CIP, 12 microg/ml; MIC of NOR, 48 microg/ml). In respect of the ParC protein, a single change at Thr57-->Ser was found in 3 isolates (MICs of NA, >256 microg/ml; MICs of CIP, 0.19~0.25 microg/ml; MICs of NOR, 1 microg/ml). At the same time, these strains changed from Ser83 to Tyr in the gyrA. The result of the investigation for the prevalence of plasmid-mediated quinolone resistance (PMQR) genes, 14 isolates harbored qnr gene among 40 isolates. All of 14 isolates showed decreased susceptibility at NA (MICs 4~16 microg/ml) and except one strain, all of qnr genes were identified as qnrB. Mutations in the gyrA gene and production of PMQR determinants were critical for quinolone resistance and decreased susceptibility to fluoroquinolone in these isolates.

Keyword

Non-typhoid Salmonella; Nalidixic acid; Mutation; PMQR

MeSH Terms

Ciprofloxacin
Codon
Diarrhea
DNA Topoisomerase IV
Humans
Microbial Sensitivity Tests
Nalidixic Acid
Norfloxacin
Point Mutation
Polymerase Chain Reaction
Prevalence
Salmonella
Salmonella enteritidis
Sprains and Strains
Ciprofloxacin
Codon
DNA Topoisomerase IV
Nalidixic Acid
Norfloxacin

Reference

1. Collazo CM, Galán JE. Requirement for exported proteins in secretion through the invasion-associated type III system of Salmonella Typhimurium. Infect Immun. 1996. 64:3524–3531.

2. Darwin KH, Miller VL. Molecular basis of the interaction of Salmonella with the intestinal mucosa. Clin Microbiol Rev. 1999. 12:405–428.

3. Nógrády N, Gadó I, Tóth A, Pászti J. Antibiotic resistance and class 1 integron patterns of non-typhoidal human Salmonella serotypes isolated in Hungary in 2002 and 2003. Int J Antimicrob Agents. 2005. 26:126–132.

4. Ruiz J. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother. 2003. 51:1109–1117.

5. Choi SH, Woo JH, Lee JE, Park SJ, Choo EJ, Kwak YG, et al. Increasing incidence of quinolone resistance in human non-typhoid Salmonella enterica isolates in Korea and mechanisms involved in quinolone resistance. J Antimicrob Chemother. 2005. 56:1111–1114.

6. Ball P. Quinolone generations: natural history or natural selection? J Antimicrob Chemother. 2000. 46:17–24.

7. Paton JH, Reeves DS. Fluoroquinolone antibiotics. Microbioloy, pharmacokinetics and clinical use. Drugs. 1988. 36:193–228.

8. Vila J. White DG, Alekshun MN, McDermotte PF, editors. Fluoroquinolone resistance. Frontiers in antimicrobial resistance: a tribute to Stuart B. Levy. 2005. Herndon, VA: ASM Press;41–52.

9. Everett MJ, Jin YF, Ricci V, Piddock LJ. Contributions of individual mechanisms to fluoroquinolone resistance of 36 Escherichia coli strains isolated from humans and animals. Antimicrob Agents Chemother. 1996. 40:2380–2386.

10. Giraud E, Brisabois A, Martel JL, Chaslus-Dancla E. Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone resistant strains in the field. Antimicrob Agents Chemother. 1999. 43:2131–2137.

11. Robicsek A, Strahilevitz J, Sahm DF, Jacoby GA, Hooper DC. Qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother. 2006. 50:2872–2874.

12. Park CH, Robicsek A, Jacoby GA, Sahm D, Hooper DC. Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin modifying enzyme. Antimicrob Agents Chemother. 2006. 50:3953–3955.

13. Kang HY, Tamang MD, Seol SY, Kim JM. Dissemination of plasmid-mediated qnr, aac(6)-Ib-cr, and qepA genes among 16S rRNA methylase producing Enterobacteriaceae in Korea. J Bacteriol Virol. 2009. 39:173–182.

14. Fàbrega A, Sánchez-Céspedes J, Soto S, Vila J. Quinolone resistance in the food chain. Int J Antimicrob Agents. 2008. 31:307–315.

15. Hwang IS, Song JY, Kim WJ, Jeong HW, Kim MS, Cheong HJ. Prevalence and mechanisms of low level quinolone resistance among non-typhoidal Salmonella isolates from human and poultry/livestock in Korea: usefulness of nalidixic acid resistance test. Infect Chemother. 2010. 42:230–236.

16. Lunn AD, Fàbrega A, Sánchez-Céspedes J, Vila J. Prevalence of mechanisms decreasing quinolone-susceptibility among Salmonella spp. clinical isolates. Int Microbiol. 2010. 13:15–20.

17. Lee K, Lee M, Lim J, Jung J, Park Y, Lee Y. Contamination of chicken meat with Salmonella enterica serovar Haardt with nalidixic acid resistance and reduced fluoroquinolone susceptibility. J Microbiol Biotechnol. 2008. 18:1853–1857.

18. Hamidian M, Tajbakhsh M, Tohidpour A, Rahbar M, Zali MR, Walther-Rasmussen J. Detection of novel gyrA mutations in nalidixic acid-resistant isolates of Salmonella enterica from patients with diarrhoea. Int J Antimicrob Agents. 2011. 37:360–364.

19. Jeong HS, Kim JA, Shin JH, Chang CL, Jeong J, Cho JH, et al. Prevalence of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes in Salmonella isolated from 12 tertiary-care hospitals in Korea. Microb Drug Resist. 2011. 17:551–557.

20. Kim KY, Park JH, Kwak HS, Woo GJ. Characterization of the quinolone resistance mechanism in foodborne Salmonella isolates with high nalidixic acid resistance. Int J Food Microbiol. 2011. 146:52–56.

21. Piddock LJ. Mechanisms of fluoroquinolone resistance: an update 1994-1998. Drugs. 1999. 58:Suppl 2. 11–18.

22. Eaves DJ, Randall L, Gray DT, Buckley A, Woodward MJ, White AP, et al. Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica. Antimicrob Agents Chemother. 2004. 48:4012–4015.

23. Ling JM, Chan EW, Lam AW, Cheng AF. Mutations in topoisomerase genes of fluoroquinolone-resistant Salmonellae in Hong Kong. Antimicrob Agents Chemother. 2003. 47:3567–3573.

24. Cattoir V, Nordmann P. Plasmid-mediated quinolone resistance in Gram-nagative bacterial species: an update. Curr Med Chem. 2009. 16:1028–1046.

25. Shin JH, Jung HJ, Lee JY, Kim HR, Lee JN, Chang CL. High rates of plasmid-mediated quinolone resistance QnrB variants among ciprofloxacin-resistant Escherichia coli and Klebsiella pneumoniae from urinary tract infections in Korea. Microb Drug Resist. 2008. 14:221–226.

26. Yu F, Chen Q, Yu X, Pan J, Li Q, Yang L, et al. High prevalence of plasmid-mediated quinolone resistance determinant aac(6')-Ib-cr amongst Salmonella enterica serotype Typhimurium isolates from hospitalised paediatric patients with diarrhoea in China. Int J Antimicrob Agent. 2011. 37:152–155.

27. Sjölund-Karlsson M, Folster JP, Pecic G, Joyce K, Medalla F, Rickert R, et al. Emergence of plasmid-mediated quinolone resistance among non-typhi Salmonella enterica isolates from humans in the United States. Antimicrob Agents Chemother. 2009. 53:2142–2144.

28. Taguchi M, Kawahara R, Seto K, Inoue K, Hayashi A, Yamagata N, et al. Plasmid-mediated quinolone resistance in Salmonella isolated from patients with overseas travelers' diarrhea in Japan. Jpn J Infect Dis. 2009. 62:312–314.